首页> 外文期刊>Journal of Krishna Institute of Medical Sciences University. >Modafinil and Learning and Memory- Is there a Connection? Evaluation of the Effect of Modafinil on Learning and Memory in Wistar Rats.
【24h】

Modafinil and Learning and Memory- Is there a Connection? Evaluation of the Effect of Modafinil on Learning and Memory in Wistar Rats.

机译:莫达非尼与学习和记忆-是否存在联系?评价莫达非尼对Wistar大鼠学习和记忆的作用。

获取原文
           

摘要

Background: Modafinil, a drug approved for use innarcolepsy, has shown conflicting effects on cognition.This study was conducted to observe the effects ofModafinil on learning and memory following acute andchronic administration in Wistar rats. Aim andObjectives: To observe the effects of Modafinil onlearning and memory following acute and chronicadministration. Material and Methods: The studyconducted in 42 male Wistar rats, had seven groups:Group I: Control, Group II: Negative Control(Vehicle), Group III: Standard Control (Donepezil),Group IV: Chronic Modafinil 10 mg/kg, Group V:Chronic Modafinil 20 mg/kg, Group VI: AcuteModafinil 10 mg/kg, Group VII: Acute Modafinil 10mg/kg. All drugs were administered for 15 days.Scopolamine was used to induce amnesia on the 15thday in all groups except Group I. Using the Hebb-William maze, baseline learning score was recorded onday 1, and post-treatment learning scores wererecorded on days 15 and 16. Results: On days 15 and16, the learning scores significantly decreased in GroupI, while it significantly increased in group II, comparedto baseline, indicating induction of amnesia byscopolamine. In Group III the learning scores on days15 and 16 (8.66 ± 2.63, 9.66 ± 2.75, in seconds) weredecreased significantly compared to baseline (18.83 ±2.65), indicating a reversal of scopolamine-inducedamnesia. All doses of Modafinil (Acute 10 mg and 20 mg/kg, Chronic 10 mg and 20 mg/kg) showed a statistically significant increase in learning scores on days 15 and 16, compared to baseline, indicating no reversal of scopolamine-induced amnesia. Conclusion: Modafinil in doses of 10 mg/kg and 20 mg/kg, given either as a single dose or over a period of time, does not reverse amnesia induced by scopolamine in rats.
机译:背景:莫达非尼是一种批准用于麻醉性发作性睡病的药物,在认知方面显示出矛盾的作用。本研究旨在观察莫达非尼对Wistar大鼠急性和慢性给药后对学习和记忆的影响。目的和目的:观察莫达非尼在急性和慢性给药后对学习和记忆的影响。材料与方法:该研究在42只雄性Wistar大鼠中进行,分为7组:第一组:对照组,第二组:阴性对照组(车辆),第三组:标准对照组(Donepezil),第四组:慢性莫达非尼10 mg / kg,组V:慢性莫达非尼20 mg / kg,VI组:急性莫达非尼10 mg / kg,VII组:急性莫达非尼10mg / kg。所有药物均服药15天。除第一组外,所有组均在第15天使用大pol碱诱发失忆症。使用Hebb-William迷宫在第1天记录基线学习成绩,在第15天和第15天记录治疗后学习成绩。 16.结果:与基线相比,第15天和第16天,组I的学习分数显着降低,而组II的学习分数显着提高,这表明东sco碱可导致失忆。在第三组中,第15天和第16天的学习得分(8.66±2.63、9.66±2.75,以秒为单位)与基线相比(18.83±2.65)显着降低,表明东pol碱诱导的健忘症已经逆转。与基线相比,所有剂量的莫达非尼(急性10 mg和20 mg / kg,慢性10 mg和20 mg / kg)在第15天和第16天的学习成绩均显示出统计学上的显着提高,表明东amine碱所致的健忘症没有逆转。结论:莫达非尼10 mg / kg和20 mg / kg的剂量(单次或一段时间)不能逆转东pol碱所致大鼠的失忆症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号